HY-100226-10mg
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2]
|
|
COVID-19-immunoregulation
|
|
HY-100226-5mg
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2]
|
|
COVID-19-immunoregulation
|
|
HY-100226-50mg
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2]
|
|
COVID-19-immunoregulation
|
|
HY-100226-1mL
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-146356-1mg
|
MedChemexpress LLC
|
Adenylyl cyclase type 2 agonist-1 [CAS 2414908-52-2]
|
|
COVID-19-immunoregulation
|
|
HY-146356-10mg
|
MedChemexpress LLC
|
Adenylyl cyclase type 2 agonist-1 [CAS 2414908-52-2]
|
|
COVID-19-immunoregulation
|
|
HY-146356-5mg
|
MedChemexpress LLC
|
Adenylyl cyclase type 2 agonist-1 [CAS 2414908-52-2]
|
|
COVID-19-immunoregulation
|
|
HY-P1110-1mg
|
MedChemexpress LLC
|
AF12198 [CAS 185413-30-3]
|
|
COVID-19-immunoregulation
|
|
HY-P1110-5mg
|
MedChemexpress LLC
|
AF12198 [CAS 185413-30-3]
|
|
COVID-19-immunoregulation
|
|
HY-110084-10mg
|
MedChemexpress LLC
|
BTZO-1 [CAS 99420-15-2]
|
|
COVID-19-immunoregulation
|
|
HY-110084-25mg
|
MedChemexpress LLC
|
BTZO-1 [CAS 99420-15-2]
|
|
COVID-19-immunoregulation
|
|
HY-110084-5mg
|
MedChemexpress LLC
|
BTZO-1 [CAS 99420-15-2]
|
|
COVID-19-immunoregulation
|
|
HY-110084-1mL
|
MedChemexpress LLC
|
BTZO-1 [CAS 99420-15-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-132304-10mg
|
MedChemexpress LLC
|
CC-90005 [CAS 1799574-70-1]
|
|
COVID-19-immunoregulation
|
|
HY-132304-100mg
|
MedChemexpress LLC
|
CC-90005 [CAS 1799574-70-1]
|
|
COVID-19-immunoregulation
|
|
HY-132304-25mg
|
MedChemexpress LLC
|
CC-90005 [CAS 1799574-70-1]
|
|
COVID-19-immunoregulation
|
|
HY-132304-5mg
|
MedChemexpress LLC
|
CC-90005 [CAS 1799574-70-1]
|
|
COVID-19-immunoregulation
|
|
HY-132304-50mg
|
MedChemexpress LLC
|
CC-90005 [CAS 1799574-70-1]
|
|
COVID-19-immunoregulation
|
|
HY-120878-10mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-100mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-25mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-5mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-50mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-1mL
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-144501-10mg
|
MedChemexpress LLC
|
D18 [CAS 2230218-36-5]
|
|
COVID-19-immunoregulation
|
|